Methods of manufacture of immunocompatible amniotic membrane products

a technology of amniotic membrane and amniotic fluid, which is applied in the direction of embryonic cells, drug compositions, peptide/protein ingredients, etc., can solve the problems of insufficient cell viability to bestow biological effect, increase the risk of disease transmission, and inability to provide sufficient cell viability to achieve the effect of superior wound healing
US20110206776A1Inactive Publication Date: 2011-08-25OSIRIS THERAPEUTICS
28 Cites 121 Cited by

Patent Information

Authority / Receiving Office
US · United States
Current Assignee / Owner
OSIRIS THERAPEUTICS
Publication Date
2011-08-25
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

Provided herein is a placental product comprising an immunocompatible amniotic membrane. Such placental products can be cryopreserved and contain viable therapeutic cells after thawing. The placental product of the present invention is useful in treating a patient with a tissue injury (e.g. wound or burn) by applying the placental product to the injury. Similar application is useful with ligament and tendon repair and for engraftment procedures such as bone engraftment.
Need to check novelty before this filing date? Find Prior Art

Description

RELATED APPLICATIONS

[0001] This application claims priority to:

[0002] U.S. Provisional Applications Ser. No. 61 / 338,464 entitled “Selectively Immunodepleted Chorionic Membranes”, filed on Feb. 18, 2010 bearing Docket No. 22924US01,

[0003] U.S. Provisional Applications Ser. No, 61 / 338,489 entitled “Selectively Immunodepleted Amniotic Membranes”, filed on Feb. 18, 2010 bearing Docket No. 22925US01, and

[0004] U.S. Provisional Applications Ser. No, 61 / 369,562 entitled “Therapeutic Products Comprising Vitalized Placental Dispersions filed on Jul. 30, 2010 bearing Docket No 23498US01, the contents of which are hereby incorporated by reference in their entireties.

[0005] This application is being co-filed on Feb. 18, 2011 with, and incorporates by reference, applications entitled:

[0006] “Methods of Manufacture of Immunocompatible Chorionic Membrane Products”,

[0007] “Immunocompatible Chorionic Membrane Products”,

[0008] “Immunocompatible Amniotic Membrane Products”,

[0009] “Therapeutic Products Comprisi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More